文献速递运动医学

骨髓间充质干细胞治疗小鼠肌肉挫伤后愈合的应用

Application of Bone Marrow-Derived Mesenchymal Stem Cells for Muscle Healing After Contusion Injury in Mice.
PubMed 文献 · Am J Sports Med · 2020-03-05

该研究为控制性实验室研究,在小鼠肌肉挫伤模型中评估骨髓来源间充质干细胞(MSC)对肌肉愈合的组织学和生理学效果。结果显示MSC治疗组再生肌纤维数量显著高于对照组,且快肌和强直收缩力与未损伤组无差异,提示MSC联合F-127支架是肌肉挫伤的潜在疗法。

要点

  • MSC治疗组再生肌纤维数量显著高于对照组及对照+F-127组。
  • MSC治疗组28天后快肌和强直收缩力与年龄匹配未损伤组无差异。
  • 移植MSC快速衰减提示其作用可能通过旁分泌机制介导。

核心结论

  • MSC治疗增加了小鼠肌肉挫伤模型中再生肌纤维数量,并改善了快肌和强直收缩力。
  • 移植MSC的快速衰减提示该作用可能为旁分泌效应。
  • 不同剂量MSC联合F-127支架是肌肉挫伤的潜在疗法。

研究设计与样本

  • 控制性实验室研究,使用5周龄C57BL/6小鼠骨髓细胞建立永生化MSC系。
  • 36只8至10周龄小鼠建立肌肉挫伤模型,分为6组(每组6只),按注射IM2细胞剂量(0、1.25×10^5、2.5×10^5个细胞,含或不含F-127,溶于100 μL磷酸盐缓冲液)分组。
  • 挫伤后14天开始注射不同剂量MSC(含或不含F-127支架),28天后进行组织学分析和快肌与强直收缩力测量。

主要发现

  • MSC处理组肌肉显示大量再生肌纤维。
  • MSC治疗组再生肌纤维数量(均值±标准差)分别为1.25×10^5组111.6±14.77、2.5×10^5组133.4±21.44、1.25×10^5+F-127组221.89±32.65、2.5×10^5+F-127组241.5±25.95,均显著高于对照组(69±18.79)和对照+F-127组(63.2±18.98)。
  • 生理评估显示,挫伤后28天各MSC剂量治疗组的快肌和强直收缩力与年龄匹配未损伤组无差异。
  • 对照组与各MSC剂量治疗组之间在肌肉挫伤后存在显著差异。

临床怎么用

  • MSC治疗可能通过促进肌纤维再生和改善肌肉力量,为运动医学中肌肉挫伤提供潜在治疗选择。
  • 联合F-127支架的MSC治疗显示更高的再生肌纤维数量,提示支架可能增强疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Skeletal muscle injuries are very common in sports medicine. Conventional therapies have limited clinical efficacy. New treatment methods should be developed to allow athletes to return to play with better function. PURPOSE: To evaluate the in vitro differentiation potential of bone marrow-derived mesenchymal stem cells and the in vivo histologic and physiologic effects of mesenchymal stem cell therapy on muscle healing after contusion injury. STUDY DESIGN: Controlled laboratory study. METHODS: Bone marrow cells were flushed from both femurs of 5-week-old C57BL/6 mice to establish immortalized mesenchymal stem cell lines. A total of 36 mice aged 8 to 10 weeks were used to develop a muscle contusion model and were divided into 6 groups (6 mice/group) on the basis of the different dosages of IM2 cells to be injected (0, 1.25 × 105, and 2.5 × 105 cells with/without F-127 in 100 μL of phosphate-buffered saline). Histological analysis of muscle regeneration was performed, and the fast-twitch and tetanus strength of the muscle contractions was measured 28 days after muscle contusion injury, after injections of different doses of mesenchymal stem cells with or without the F-127 scaffold beginning 14 days after contusion injury. RESULTS: The mesenchymal stem cell-treated muscles exhibited numerous regenerating myofibers. All the groups treated with mesenchymal stem cells (1.25 × 105 cells, 2.5 × 105 cells, 1.25 × 105 cells plus F-127, and 2.5 × 105 cells plus F-127) exhibited a significantly higher number of regenerating myofibers (mean ± SD: 111.6 ± 14.77, 133.4 ± 21.44, 221.89 ± 32.65, and 241.5 ± 25.95, respectively) as compared with the control group and the control with F-127 (69 ± 18.79 and 63.2 ± 18.98). The physiologic evaluation of fast-twitch and tetanus strength did not reveal differences between the age-matched uninjured group and the groups treated with various doses of mesenchymal stem cells 28 days after contusion. Significant differences were found between the control group and the groups treated with various doses of mesenchymal stem cells after muscle contusion. CONCLUSION: Mesenchymal stem cell therapy increased the number of regenerating myofibers and improved fast-twitch and tetanus muscle strength in a mouse model of muscle contusion. However, the rapid decay of transplanted mesenchymal stem cells suggests a paracrine effect of this action. Treatment with mesenchymal stem cells at various doses combined with the F-127 scaffold is a potential therapy for a muscle contusion. CLINICAL RELEVANCE: Mesenchymal stem cell therapy has an effect on sports medicine because of its effects on myofiber regeneration and muscle strength after contusion injury.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Chiu CH, Chang TH, Chang SS, et al. Application of Bone Marrow-Derived Mesenchymal Stem Cells for Muscle Healing After Contusion Injury in Mice. Am J Sports Med. 2020. PMID: 32134689. doi:10.1177/0363546520905853

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。